[Prospective randomised controlled observation of tympanic chamber injection of gangliosides in the treatment of refractory sudden deafness] – PubMed Black Hawk Supplements
BLACK HAWK: High quality lions mane supplement for focus
Published article
Objective:This study aimed to evaluate the therapeutic effect of intratympanic injection of ganglioside in patients with refractory sudden deafness. Methods:A total of 120 patients with sudden deafness, aged 18-65 years, whose onset was within 11-42 days, failed to respond to conventional treatment, and had an average hearing threshold(500-4 000 Hz)>60 dB were selected. They were prospectively and randomly divided into a control group of 61 cases and an experimental group of 59 cases. The…
Black Hawk Supplements, best supplements in the UK
Randomized Controlled Trial
. 2025 Mar;39(3):218-222.
doi: 10.13201/j.issn.2096-7993.2025.03.006.
[Article in Chinese]
Affiliations
- PMID: 40049636
- DOI: 10.13201/j.issn.2096-7993.2025.03.006
Randomized Controlled Trial
[Prospective randomised controlled observation of tympanic chamber injection of gangliosides in the treatment of refractory sudden deafness]
[Article in Chinese]
Mengyuan Wang et al. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Mar.
Abstract
Objective:This study aimed to evaluate the therapeutic effect of intratympanic injection of ganglioside in patients with refractory sudden deafness. Methods:A total of 120 patients with sudden deafness, aged 18-65 years, whose onset was within 11-42 days, failed to respond to conventional treatment, and had an average hearing threshold(500-4 000 Hz)>60 dB were selected. They were prospectively and randomly divided into a control group of 61 cases and an experimental group of 59 cases. The control group was treated according to the recommended protocol of the Chinese Medical Association(postauricular injection of methylprednisolone), while the experimental group was treated with intratympanic injection of monosialotetrahexosylganglioside sodium+postauricular injection of methylprednisolone. Both groups were simultaneously administered oral ginkgo biloba extract and citicoline tablets. Hearing was re-examined two weeks after the completion of treatment, and the therapeutic effects of the two different treatment methods were compared and analyzed. Results:The effective rate was 29.51% in the control group and 54.24% in the experimental group(P<0.01). The average hearing threshold improved by 11.57 dB HL in the control group and 22.50 dB HL in the experimental group(P<0.05). Conclusion:The combination of postauricular injection of methylprednisolone and intratympanic injection of ganglioside is more effective than postauricular injection of methylprednisolone alone in the treatment of refractory sudden deafness. The earlier the treatment, the better the therapeutic effect.
目的:本研究旨在评价鼓室注射神经节苷脂在难治性突聋患者中的疗效。 方法:入选发病在11~42 d、经常规治疗无效、平均听阈(500~4 000 Hz)>60 dB的突发性聋、年龄18~65岁的患者120例,前瞻性平行随机分为对照组61例和试验组59例,对照组按照中华医学会推荐方案(耳后注射甲泼尼龙)治疗,试验组鼓室注射单唾液酸四己糖神经节苷脂钠+耳后注射甲泼尼龙治疗,2组同时口服银杏提取物和胞磷胆碱片。治疗结束2周后复查听力,对2种不同治疗方法的疗效进行比较分析。 结果:对照组有效率为29.51%,试验组有效率为54.24%(P<0.01)。对照组平均听阈改善了11.57 dB HL,试验组平均听阈改善22.50 dB HL(P<0.05)。 结论:耳后注射甲泼尼龙联合鼓室注射神经节苷脂较单纯耳后注射甲泼尼龙治疗难治性突发性聋疗效好,并且治疗越早,疗效更佳。.
Keywords: ganglioside sodium; methylprednisolone; retroauricular injection; sudden deafness; tympanic cavity injection.
Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.
Conflict of interest statement
The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.
Publication types
MeSH terms
Substances
BLACK HAWK: Best ashwagandha supplement for elderly
Read the original publication: